Showing results (71-80 of 87) with videos related to
Sort By:
Pageof 9
Bone Marrow Transplantation|August 1, 1995
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remissionR P Gale, M M Horowitz, R S Weiner, et al.Blood|April 1, 1994
Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemiaW R Drobyski, R C Ash, J T Casper, et al.Blood|October 1, 1993
Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phaseJ M Goldman, R Szydlo, M M Horowitz, et al.The New England Journal of Medicine|February 22, 1990
Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donorsR C Ash, J T Casper, C R Chitambar, et al.Blood|August 15, 1992
Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapyJ C Biggs, M M Horowitz, R P Gale, et al.Annals of Internal Medicine|April 15, 1994
Identical-twin bone marrow transplants for leukemiaR P Gale, M M Horowitz, R C Ash, et al.Bone Marrow Transplantation|August 1, 1995
Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantationR Sarode, J G McFarland, N Flomenberg, et al.Bone Marrow Transplantation|August 1, 1993
Fluorescence in situ hybridization with X and Y chromosome probes for cytogenetic studies on bone marrow cells after opposite sex transplantationG W Dewald, C R Schad, E R Christensen, et al.Blood|October 15, 1993
Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell doseW R Drobyski, C A Keever, M S Roth, et al.Blood|April 1, 1993
Experiences of the first 493 unrelated marrow donors in the National Marrow Donor ProgramD F Stroncek, P V Holland, G Bartch, et al.Pageof 9